2026 BME Seminar: Anthony Guiseppi-Eli, Sc.D.

Join the Department of Biomedical Engineering on Monday, October 12, 2026 for a Seminar Series featuring Anthony Guiseppi-Elie, Sc.D., President and Senior Fellow of American International Institute of Medical Sciences, Engineering, and Innovation (AIIMSEI). Dr. Guiseppi-Elie will discuss the convergence of engineering and medicine through an integrated curriculum that prepares both clinicians and engineers at Texas A&M University's School of Engineering Medicine, a multidisciplinary approach that drives innovations such as the Physiological Status Monitoring (PSM) BioChip™ and SMART hydrogel-based biosensors.

About Dr. Guiseppi-Elie

Dr. Anthony Guiseppi-Elie is President and Senior Fellow of the American International Institute of Medical Sciences, Engineering, and Innovation (AIIMSEI.org). He currently also serves as a Senior Dresden Fellow and Visiting Distinguished Professor at the Technical University of Dresden, Germany.

Dr. Guiseppi-Elie brings over three decades of experience bridging academia, industry, and innovation. He has spent 15 years in industrial research and product development, and 18 years as a tenured, titled, and endowed professor at leading institutions including Virginia Commonwealth University, Clemson University, Texas A&M University (TAMU), and Anderson University. At TAMU, he was Head of the Department of Biomedical Engineering and co-founded the School of Engineering Medicine (ENMED), where he also served as the Founding Associate Dean of Engineering Innovation. At Anderson University, he was Vice President of Industry Relations and Founding Dean of the College of Engineering. His academic appointments span departments of Chemical En2026 gineering, Biomedical Engineering, Electrical and Computer Engineering, and Emergency Medicine. He earned his Sc.D. in Materials Science and Engineering from the MIT, M.Sc. in Chemical Engineering from the University of Manchester (UMIST), and B.Sc. (First Class Honors) from the University of the West Indies (UWI). He has published over 225 peer-reviewed publications, holds 8 U.S. patents, and has an h-index of 53 (11,111 citations) (07.2026). He has been an IEEE-EMBS Distinguished Lecturer, the 2013 Avis Visiting Professor in Pharmaceutics at the University of Tennessee, a Fulbright Specialist (2015–2019), and has since 2020 been named by Stanford University to the top 2% of scientists worldwide. He is a Fellow of IEEE, AIMBE, BMES, RSC, and RSM. His research focuses on physiological monitoring during hemorrhagic trauma and allotransplantation, stimuli-responsive polymeric nanobiomaterials for drug delivery and tissue regeneration, and the development of microanalytical systems for advancing human health and medicine.